NYSE:TMO - Thermo Fisher Scientific Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$211.20 -0.87 (-0.41 %)
(As of 07/15/2018 04:00 PM ET)
Previous Close$211.20
Today's Range$210.74 - $212.6050
52-Week Range$170.07 - $226.44
Volume863,807 shs
Average Volume1.23 million shs
Market Capitalization$84.97 billion
P/E Ratio21.33
Dividend Yield0.32%
Thermo Fisher Scientific logoThermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services


Debt-to-Equity Ratio0.69
Current Ratio1.36
Quick Ratio0.95


Trailing P/E Ratio21.33
Forward P/E Ratio19.36
P/E Growth1.55

Sales & Book Value

Annual Sales$20.92 billion
Price / Sales4.06
Cash Flow$14.4856 per share
Price / Cash14.58
Book Value$63.38 per share
Price / Book3.33


EPS (Most Recent Fiscal Year)$9.49
Net Income$2.23 billion
Net Margins10.24%
Return on Equity16.09%
Return on Assets7.35%


Outstanding Shares402,320,000
Market Cap$84,970.62

The Truth About Cryptocurrencies

Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific announced a quarterly dividend on Thursday, May 24th. Stockholders of record on Friday, June 15th will be given a dividend of $0.17 per share on Monday, July 16th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date is Thursday, June 14th. View Thermo Fisher Scientific's Dividend History.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) issued its earnings results on Wednesday, April, 25th. The medical research company reported $2.50 earnings per share for the quarter, beating analysts' consensus estimates of $2.42 by $0.08. The medical research company had revenue of $5.85 billion for the quarter, compared to analyst estimates of $5.62 billion. Thermo Fisher Scientific had a net margin of 10.24% and a return on equity of 16.09%. The business's revenue was up 22.8% compared to the same quarter last year. During the same period in the previous year, the company earned $2.08 EPS. View Thermo Fisher Scientific's Earnings History.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Thermo Fisher Scientific.

What guidance has Thermo Fisher Scientific issued on next quarter's earnings?

Thermo Fisher Scientific updated its FY18 earnings guidance on Wednesday, May, 23rd. The company provided EPS guidance of $10.80-10.96 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $10.91. The company issued revenue guidance of $23.6-23.9 billion, compared to the consensus revenue estimate of $23.82 billion.

What price target have analysts set for TMO?

12 brokerages have issued 1-year price targets for Thermo Fisher Scientific's shares. Their forecasts range from $195.00 to $250.00. On average, they expect Thermo Fisher Scientific's share price to reach $228.30 in the next year. This suggests a possible upside of 8.1% from the stock's current price. View Analyst Ratings for Thermo Fisher Scientific.

What is the consensus analysts' recommendation for Thermo Fisher Scientific?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last year. There are currently 1 hold rating and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:
  • Mr. Marc N. Casper, CEO, Pres & Director (Age 50)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 51)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 55)
  • Mr. Gregory J. Herrema, Sr. VP & Pres of Customer Channels (Age 52)
  • Mr. Patrick M. Durbin, Sr. VP & Pres of Specialty Diagnostics (Age 51)

Has Thermo Fisher Scientific been receiving favorable news coverage?

Headlines about TMO stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Thermo Fisher Scientific earned a daily sentiment score of 0.07 on Accern's scale. They also assigned media coverage about the medical research company an impact score of 47.53 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Who are Thermo Fisher Scientific's major shareholders?

Thermo Fisher Scientific's stock is owned by a number of of institutional and retail investors. Top institutional investors include NN Investment Partners Holdings N.V. (0.25%), Gofen & Glossberg LLC IL (0.08%), Handelsbanken Fonder AB (0.08%), Caledonia Investments PLC (0.04%), Confluence Investment Management LLC (0.04%) and Addenda Capital Inc. (0.03%). Company insiders that own Thermo Fisher Scientific stock include C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Seth H Hoogasian, Stephen Williamson, Thomas W Loewald and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Which major investors are selling Thermo Fisher Scientific stock?

TMO stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, Manning & Napier Group LLC, Clinton Group Inc., BKD Wealth Advisors LLC, Webster Bank N. A. and M. Kraus & Co. Company insiders that have sold Thermo Fisher Scientific company stock in the last year include C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Seth H Hoogasian, Stephen Williamson and William G Parrett. View Insider Buying and Selling for Thermo Fisher Scientific.

Which major investors are buying Thermo Fisher Scientific stock?

TMO stock was bought by a variety of institutional investors in the last quarter, including Gofen & Glossberg LLC IL, Caledonia Investments PLC, Handelsbanken Fonder AB, Addenda Capital Inc., Polaris Greystone Financial Group LLC, Neville Rodie & Shaw Inc., DnB Asset Management AS and Addenda Capital Inc.. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $211.20.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $84.97 billion and generates $20.92 billion in revenue each year. The medical research company earns $2.23 billion in net income (profit) each year or $9.49 on an earnings per share basis. Thermo Fisher Scientific employs 70,000 workers across the globe.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]

MarketBeat Community Rating for Thermo Fisher Scientific (NYSE TMO)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  561 (Vote Outperform)
Underperform Votes:  254 (Vote Underperform)
Total Votes:  815
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe TMO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.